ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer
Our study explored the prognostic value of ctDNA methylation in patients with advanced NSCLC undergoing targeted therapies and first revealed the predictive role of <i>SNORD3F</i>.
Authors
- Dongsheng Shi (ORCID: https://orcid.org/0000-0002-3545-4286)
- Jianwen Qin (ORCID: https://orcid.org/0000-0002-8981-9156)
- Yan Yin (ORCID: https://orcid.org/0009-0006-8197-094X)
- Guangxin Liu (ORCID: https://orcid.org/0000-0003-3894-1255)
- Yan Jiang (ORCID: https://orcid.org/0000-0003-1596-3187)
- Feng Xue (ORCID: https://orcid.org/0000-0002-5992-5927)
- Bin Liu (ORCID: https://orcid.org/0000-0003-1569-2604)
- Lei Wang (ORCID: https://orcid.org/0000-0003-1405-9815)
- Liang Zhai
- Bingtian Zhao
Institutions
- Tianjin Chest Hospital (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/cmar.s474241
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.84